DRUGS & AGING

简称 DRUG AGING ·NEW ZEALAND ·出版周期 Monthly ·年均收录 84 篇

3.8

最新影响因子

5.70%

自引率

较易

投稿难度

较慢,6-12周

审稿周期

期刊简介

DRUGS & AGING是一本国际学术期刊，ISSN号为1170-229X，由新西兰出版商Adis International Ltd（现属于Springer Nature集团）出版，出版地为奥克兰，出版周期为月刊。该杂志的影响因子根据最新JCR数据约为3.5，属于非开放获取（非OA）期刊，被SCI收录，在中科院分区中通常位于医学大类3区或4区。其发文特点集中于老年医学与药物治疗学交叉领域，重点关注老年人用药安全、药物代谢、年龄相关疾病（如阿尔茨海默病、骨质疏松）的药物治疗及临床药理学研究，尤其欢迎随机对照试验、系统评价和循证医学研究。杂志质量中等偏上，审稿周期约3个月，但需注意其近年自引率略高（约15%），存在潜在被SCI预警风险，投稿时可结合研究方向与期刊偏好综合评估。

影响因子趋势

近期发表

Differences in Anticholinergic Exposure Assessment Across Burden Scales and Exposure Measures in a Population-Based Study: Implications for Targeted Deprescribing in Older Adults 2026-09-15

Creating Awareness of preScribing Cascades and Managing Adverse Drug Effects (CASC-ADE) Tool: Appraisal by Future End Users 2026-09-09

Longitudinal Adherence Trajectories of First-Line Nucleotide Analogues among US Older Adults with Chronic Hepatitis B 2026-09-06

Influence of Ageing on the Pharmacology, Efficacy and Safety of Oral Targeted Therapies for Inflammatory Bowel Disease: Focus on Janus Kinase (JAK) Inhibitors and Sphingosine-1-Phosphate (S1P) Receptor Modulators 2026-09-07

Management of Urinary Retention in Older Women 2026-08-31

Opioids to Treat Chronic Pain in the Older Adult: A Clinical Consensus to Guarantee Safety and Avoid Adverse Events 2026-08-21

Clinical and Economic Outcomes of Korea’s National Polypharmacy Management Program for Hospitalized Older Adults: 90-Day Readmission and Healthcare Costs 2026-08-08

Body Mass Index Category and the Association Between Polypharmacy and Functional Recovery in Stroke Patients: A Retrospective Cohort Study 2026-08-04

Loneliness and Initiation of Potentially Inappropriate Pain and Psychotropic Medications: A Retrospective Cohort Study 2026-07-31

Caring for Older Adults with Acute Myeloid Leukemia: Best Practices for Aligning Patient Fitness and Preference with Available Therapies 2026-07-27